Exact Sciences Corp.


EXAS

Price

69.06


Change

2.18


High

71.62


Low

67.18


Avg Volume

1,961,585


PE Ratio

-61.12


52 Week High

100.77


52 Week Low

56.05



Profile

Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer. Exact Sciences Corp. launched Cologuard in 2014, the first stool DNA test for colorectal cancer. The company was founded in 1995 in Marlborough, Massachusetts, but today it is headquartered in Madison, Wisconsin. In January 2001, the company had its initial public offering on NASDAQ.


Top Streaming News


Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.

Data provided by IEX Cloud

About

Copyright © 2020 Finaza.IO. All Rights Reserved.